Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting

Conclusions:
The cost of COPD may vary according to compliance with the GOLD guidelines. The cost observed for patients with stage II disease is higher than expected in patients who adhere to treatment, but patients with stage III disease treated according to the GOLD guidelines had significantly higher treatment costs.

Source: Therapeutic Advances in Respiratory Disease - May 23, 2013 Category: Respiratory Medicine Authors: Miravitlles, M., Sicras, A., Crespo, C., Cuesta, M., Brosa, M., Galera, J., Lahoz, R., Lleonart, M., Riera, M. I. Tags: Original Research Source Type: research